Notice of Closed Meeting, 6551 [2022-02380]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
The
single-source award will support the
National AIDS Control Program of Sierra
Leone (SL) in the Ministry of Health and
Sanitation to implement HIV strategic
information and laboratory
strengthening activities in SL. This
award will build and strengthen
laboratories that are equipped with the
appropriate diagnostic technologies,
trained and skilled staff, and systems
that have the capability to provide
efficient services. It will also strengthen
SI systems, data quality assurance and
capacity of staff responsible for
managing facility-based survey and
surveillance data operating at national
and subnational levels. As the mandated
institution to provide HIV treatment
clinical services and guidelines in SL,
the Sierra Leone Ministry of Health and
Sanitation is in a unique position to
conduct this work. The National HIV/
AIDS control program is one of the
specialized programs within the
Ministry of Health.
SUPPLEMENTARY INFORMATION:
Summary of the Award
Recipient: Sierra Leone Ministry of
Health and Sanitation.
Purpose of the Award: The purpose of
this award is to build laboratory and SI
capacity to improve the provision of
HIV testing, treatment, and retention in
line with HIV epidemic control and 95–
95–95 targets. The award will build and
strengthen laboratories that are
equipped with the appropriate
diagnostic technologies, trained and
skilled staff, and systems that have the
capability to provide efficient services.
Amount of Award: The approximate
year 1 funding amount will be $450,000
in Federal Fiscal Year (FFY) 2022 funds,
subject to the availability of funds.
Funding amounts for years 2–5 will be
set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
lotter on DSK11XQN23PROD with NOTICES1
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–02407 Filed 2–3–22; 8:45 am]
18:50 Feb 03, 2022
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Delegation of Authority
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE–22–013: Rigorous Evaluation
of Community-Centered Approaches for
the Prevention of Community Violence.
Date: June 28–29, 2022.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Official, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 256001
6551
Notice is hereby given that the
Director, Centers for Disease Control
and Prevention (CDC), has delegated to
the Chief Operating Officer, CDC,
without the authority to redelegate, the
authority vested in the Secretary of HHS
by section 212(1) of the Department of
Defense and Labor, Health and Human
Services, and Education Appropriations
Act, 2019 and Continuing
Appropriations Act, 2019 (FY 19 HHS
Appropriations Act) Public Law 115–
245, division B, title II, or substantially
similar authorities vested in the
Secretary in the future by Congress, in
order to carry out international health
activities.
Section 212(1) of the FY19 HHS
Appropriations Act permits the
Secretary of HHS to exercise authority
equivalent to that available to the
Secretary of State under 22 U.S.C
2669(c) to award personal services
contracts for work performed in foreign
countries. The authority delegated
herein includes the authority to
determine the necessity of negotiating,
executing, and performing such
contracts without regard to statutory
provisions as related to the negotiation,
making, and performance of contracts
and performance of work in the United
States.
The authority under section 212(1) is
immediately revoked in the event that
any subsequent fiscal year HHS
appropriations act does not contain the
provision currently in section 212(1) or
substantially similar authority.
The Chief Operating Officer, CDC,
shall consult with the Secretary of State
and relevant Chief of Mission to ensure
that this authority is exercised in a
manner consistent with section 207 of
the Foreign Service Act of 1980 and
other applicable statutes administered
by the Department of State.
This delegation supersedes the
delegation of similar name, approved by
the Director, CDC, on March 17, 2020.
This delegation became effective on
January 31, 2022. The Director, CDC,
affirms and ratifies any actions taken
that involve the exercise of the authority
delegated herein prior to the effective
date of this delegation.
Sherri A. Berger,
Chief of Staff, Centers for Disease Control
and Prevention.
[FR Doc. 2022–02380 Filed 2–3–22; 8:45 am]
[FR Doc. 2022–02328 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02380]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-- RFA-CE-22-013: Rigorous
Evaluation of Community-Centered Approaches for the Prevention of
Community Violence.
Date: June 28-29, 2022.
Time: 8:30 a.m.-5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific
Review Official, National Center for Injury Prevention and Control,
CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341,
Telephone (404) 639-0913, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-02380 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
